To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Efficacy & Safety of Topical Tranexamic Acid in Elderly Hip Fractures Undergoing Surgical Treatment

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2025

Efficacy & Safety of Topical Tranexamic Acid in Elderly Hip Fractures Undergoing Surgical Treatment

Vol: 307| Issue: 8| Number:42| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Efficacy and Safety of Topical Tranexamic Acid in Elderly Hip Fractures Undergoing Surgical Treatment: Meta-Analysis of Randomized Controlled Trials.

Clin Orthop Surg . 2025 Feb;17(1):16-28. doi: 10.4055/cios24184.

Contributing Authors:
S Artykbay P Susantitaphong S Tantavisut

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Nine randomized controlled trials including 1,024 elderly patients with hip fractures were included in this systematic review and meta-analysis comparing topical tranexamic acid (TXA) with intravenous TXA or placebo. Pooled outcomes of interest included transfusion rates, transfused blood units, hemoglobin drop, hematocrit loss, total blood loss, drain output, hospital stay, surgery duration, deep...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue